These data show that PARP7 can be induced by AHR in AR+ (CWR22Rv1) and AR− (PC3 and DU145) prostate cancer cells for the purpose of sensitizing cells to RBN2397 (Supplementary Fig. S2B and S2C). Here, TIPARP is linked to prostate carcinoma.